Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.169ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.43ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.42ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AE.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.442ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.447ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.110.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.180ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.155ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.92ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.145ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.120ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.77ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AE.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.504ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20103.9China
AE.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.201ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.221ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.410ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.411ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.109ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.361ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.38ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.417ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.46ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.139ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.508ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.94ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.463ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.357ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.318ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.557ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.119ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.160ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
D.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.134ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.393ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.381ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.32ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AE.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.516ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.526ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.279ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AE.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
N.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.36ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.450ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.130ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.444ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used